Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The tryptophan-free amino acid drink (TFD) is an experimental research compound used as a challenge agent to induce acute tryptophan depletion (ATD). By providing a concentrated mixture of large neutral amino acids (LNAAs) while excluding tryptophan, the drink stimulates hepatic protein synthesis and creates intense competition for the LNAA transporter at the blood-brain barrier. This results in a rapid, temporary reduction in plasma and brain tryptophan levels, which is the essential precursor for serotonin (5-HT) biosynthesis. TFD is widely utilized in clinical research to investigate the role of the serotonergic system in mood regulation, cognitive function, sleep architecture, and the pathophysiology of psychiatric disorders such as major depressive disorder and alcohol dependence.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tryptophan-free amino acid drink.